Norrlands universitetssjukhus i Umeå är ett svenskt sjukhus som drivs av Region Västerbotten. Sjukhuset är granne med Umeå universitet och har också ett nära samarbete med dess medicinska fakultet. Sjukhuset är det största i Norrland och bland de största i landet.

During the past decade, Norrlands Uni Hospital; Onkologi Avd. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norrlands Uni Hospital; Onkologi Avd." #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "DexTech Medical AB" with 3 trials sponsored, "Ass. Prof. Jan Nyman" with 2 trials sponsored, "Nordic Lymphoma Group" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norrlands Uni Hospital; Onkologi Avd." #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Norrlands Uni Hospital; Onkologi Avd." are "Prostate Cancer Metastatic" (3 trials), "Breast Cancer" (2 trials), "Glioblastoma" (2 trials), "Non Small Cell Lung Cancer" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Norrlands Uni Hospital; Onkologi Avd." in a lesser frequency.

Most popular intervention types in "Norrlands Uni Hospital; Onkologi Avd." are "Drug" (13 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (4 trials), "Placebo" (4 trials), "Osteodex" (3 trials), "Paclitaxel" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Norrlands Uni Hospital; Onkologi Avd." are 11 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Norrlands Uni Hospital; Onkologi Avd.". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Norrlands Uni Hospital; Onkologi Avd., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Norrlands Uni Hospital; Onkologi Avd., 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".